Last reviewed · How we verify
Umbilical Cord Blood administration — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Umbilical Cord Blood administration (Umbilical Cord Blood administration) — MinYoung Kim, M.D..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Umbilical Cord Blood administration TARGET | Umbilical Cord Blood administration | MinYoung Kim, M.D. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Umbilical Cord Blood administration CI watch — RSS
- Umbilical Cord Blood administration CI watch — Atom
- Umbilical Cord Blood administration CI watch — JSON
- Umbilical Cord Blood administration alone — RSS
Cite this brief
Drug Landscape (2026). Umbilical Cord Blood administration — Competitive Intelligence Brief. https://druglandscape.com/ci/umbilical-cord-blood-administration. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab